G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?
Asher Ornoy,Gideon Koren +1 more
TL;DR: Judging from the new population registry‐based studies with comparison to disease controls, there seems to be no demonstrable increase in the rate of major anomalies, prematurity, small for gestational age, or miscarriage, and the risk associated with treatment discontinuation appears to outweigh the fetal and neonatal risks of maternal treatment.
Journal ArticleDOI
Evaluation of drug formularies for pediatric intensive care.
TL;DR: It is shown that four commonly used drug formularies give few and widely differing dosing guidelines for drugs prescribed in the intensive care unit, and Physicians should be aware of the limitations of these formularie for daily practice in this group of vulnerable patients.
Journal ArticleDOI
Hair cortisol - a potential biological marker for chronic stress
TL;DR: It is hypothesized that cortisol levels measured in hair may correlate better with chronic stress, and salivary cortisol levels used as a biomarker of stress cannot accurately reflect chronic stress.
Journal Article
Alcohol consumption among women.
Irene Zelner,Gideon Koren +1 more
TL;DR: This review presents and synthesizes studies conducted worldwide on alcohol consumption by pregnant women, risk factors associated with gestational drinking, as well as doses and definitions of drinking behaviours.
Journal ArticleDOI
A Double-Blind, Placebo-Controlled Trial of Transdermal Fentanyl After Abdominal Hysterectomy: Analgesic, Respiratory, and Pharmacokinetic Effects
Alan N. Sandler,Alan D. Baxter,Joel Katz,Benoit Samson,Mark Friedlander,Peter H. Norman,Gideon Koren,S. Roger,Kathryn A. Hull,Julia Klein +9 more
TL;DR: Application of TTSF patches 2 h preoperatively is associated with moderate supplementary opioid requirements for analgesia in the early postoperative period and ongoing opioid supplementation for at least 72 h and a high incidence of respiratory depression requiring intensive monitoring, oxygen supplementation, and removal of the T TSF patches.